AstraZeneca plc (ADR) (AZN), Sanofi SA (ADR) (SNY): Don’t Ignore These European Healthcare Stocks
Healthcare stocks have rallied over the past couple years, and for good reason.
Posts Tagged ‘Astrazeneca Plc (AZN)’
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN), Omthera Pharmaceuticals Inc (OMTH): Three Stocks Near 52-Week Lows Worth Buying
Just as we examine companies each week that may be rising past their fair value, we can also find companies potentially trading at bargain prices.
What These Ratios Tell Us About GlaxoSmithKline plc (ADR) (GSK)
These two ratios provide an indication of how successful a company is at generating profits using shareholders' funds and debt, and they have a strong influence on dividend payments...
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): Will These Pharma Stocks Maintain Their Yields?
High dividend pharmaceutical stocks have been extremely popular in recent years.
Why I Think GlaxoSmithKline plc (GSK) Is So Much More Than Just an Income Stock
Indeed, the shares currently yield an impressive 4.4% despite rising by more than 30% in the last three years alone.
AstraZeneca plc (ADR) (AZN): Is This Purchase a Game-Changer?
London-based pharmaceutical giant AstraZeneca plc (ADR) (NYSE:AZN) recently announced that it had agreed to purchase U.S.-based lung-drug manufacturer Pearl Therapeutics for at...
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Top Treatments for High Cholesterol
About a third of American adults have high LDL cholesterol -- that's the bad kind -- but less than half of adults with high LDL seek treatment, according to the Centers for Disease...
Eli Lilly & Co. (LLY), Merck & Co., Inc. (MRK): Another Alzheimer’s Disease Failure
The latest drug to bite the dust is LY2886721, a beta secretase, or BACE, inhibitor.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK): A Big Pharma Company With a Juicy Dividend Yield and Low Valuation
Recently, AstraZeneca plc (ADR) (NYSE:AZN) announced that it has agreed to acquire Pearl Therapeutics, the respiratory drug manufacturer, in a transaction worth around $1.15 billion...
Pfizer Inc. (PFE), Puma Biotechnology Inc (PBYI): Strong Product Pipelines Have Pharmaceutical Companies Poised for Growth
With the global economy beginning to stabilize, the stock market is looking more attractive than ever.
The Stock Picker’s Guide to AstraZeneca plc (AZN)
In this series, I'm subjecting companies to scrutiny under five headings: prospects, performance, management, safety, and valuation.
AstraZeneca plc (ADR) (AZN), Novartis AG (ADR) (NVS): 5 Biotech Giants with Lucrative Dividend Yields
Investing in biotech stocks is relatively risky amid the volatility of the market. There are many factors that can greatly affect share trends and price performance.
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): Is Concentration Better Than Diversification in Pharma?
Pfizer Inc. (NYSE:PFE) recently completed the spin-off of its animal health unit, Zoetis Inc (NYSE:ZTS).
ACADIA Pharmaceuticals Inc. (ACAD): What’s Next For This Biotech?
ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD)’ 1,100% gain makes it one of the best performing stocks in the market.
Regeneron Pharmaceuticals Inc. (REGN), GlaxoSmithKline plc (GSK): The First Real Cure in the $25 billion Asthma Market?
Everyone has had a friend at school who was asthmatic. Life is not easy for the chronic asthmatic.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): Looking to Return Capital to Shareholders Via Debt-Fueled Share Buyback
Pharmaceutical giant Merck & Co., Inc.
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN): A Winning Biotechnology Bet
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has recently launched its primary product candidate Vascepa into the market.
AstraZeneca plc (ADR) (AZN)’s Acquisition of Omthera Pharmaceuticals Inc (OMTH) Is a Desperate Act
AstraZeneca plc (ADR) (NYSE:AZN) announced the acquisition of Omthera Pharmaceuticals Inc (NASDAQ:OMTH), a company that went public just last month (April 11).
GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK): Why You Should Care About This Diabetes Drug Saga
GlaxoSmithKline plc (ADR) (NYSE:GSK)'s diabetes drug Avandia causes heart issues. Or maybe it doesn't.
Rigel Pharmaceuticals, Inc. (RIGL), Synta Pharmaceuticals Corp. (SNTA): Three Horrendous Health-Care Stocks This Week
Many stocks encountered turbulence this week, but few were blown about like several biotech stocks.
Galena Biopharma Inc (GALE), Oncolytics Biotech, Inc. (USA) (ONCY): 2 Drugs With Acquisition Potential
Big pharmaceutical players, known as Big Pharma, depend on patents to fend of generic threats to their blockbuster drugs.
How AstraZeneca plc (ADR) (AZN) Measures Up as a GARP Investment
LONDON -- A popular way to dig out reasonably priced stocks with robust growth potential is through the "Growth at a Reasonable Price," or GARP, strategy.
Vodafone Group Plc (ADR) (VOD), Tate & Lyle PLC (TATE): Neil Woodford’s Latest Buys and Sells
Through his Invesco Perpetual Income and High Income funds, Woodford looks after more than 20 billion pounds of client money.
AstraZeneca plc (ADR) (AZN), Select Medical Holdings Corporation (SEM), Meridian Bioscience, Inc. (VIVO): Three High Dividend Healthcare Stocks
The U.S. government has been consistently cutting rates for the last few years. The aim of this exercise is to jump start the sluggish U.S. economy.
AstraZeneca plc (ADR) (AZN): This Pharma Company Is Making the Right Moves
Mergers and acquisitions appear to be continuously reshaping the pharmaceuticals industry.
Amarin Corporation plc (ADR) (AMRN): This Drugmaker Should Go Fishing for a Marketing Partner
The biotechnology sector is rapidly evolving, and what was a near-guarantee of success of getting a drug approved by the Food and Drug Administration 10 years ago is no longer...
AstraZeneca plc (ADR) (AZN), Electronic Arts Inc. (EA): Stocks Are at All-Time Highs…Is it Time to Sell?
Unless you have a crystal ball, you can't time the market. So don't try it; just stay in the market as a whole.
Sanofi SA (ADR) (SNY), GlaxoSmithKline plc (ADR) (GSK), Johnson & Johnson (JNJ): 5 Costliest Microbes in Financial History
The field of synthetic biology is still in its infancy, with many of the most promising companies residing outside of public markets, but make no mistake: The bioeconomy is on...
VIVUS, Inc. (VVUS), Arena Pharmaceuticals, Inc. (ARNA): This Obesity Drugmaker Is Badly In Need of a Marketing Partner
As recently as a decade ago, the biggest hurdle for biotech companies wasn't competition from their peers or even the sale price of their drugs.
Amarin Corporation plc (ADR) (AMRN), AstraZeneca plc (ADR) (AZN): Right Drug Class, Wrong Company
We've been speculating for almost a year that Amarin Corporation plc (ADR) (NASDAQ:AMRN) would be purchased by AstraZeneca plc (ADR) (NYSE:AZN).
Amarin Corporation plc (ADR) (AMRN) News: Struggle, New Announcement & AstraZeneca Plc (AZN)’s Dominance
Amarin Corporation plc (ADR) (NASDAQ:AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to ...
The City News: InterContinental Hotels Group PLC (IHG), Barclays PLC (BARC), GlaxoSmithKline plc (GSK) & More
Editor's Note: Related tickers: JPMorgan Chase & Co.
AstraZeneca plc (ADR) (AZN), GlaxoSmithKline plc (ADR) (GSK), Merck & Co., Inc. (MRK), Eli Lilly & Co. (LLY), AbbVie Inc (ABBV): The 5 Highest-Paying Dividend Stocks in Big Pharma
Any investor looking for the highest-paying dividend stocks would do well to start in Big Pharma, where many of the top picks offer yields in excess of 3% or 4%.
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): The Top Three Diseases Caused by Stress
Let's face it; we all dislike stress, but it's something we all live with to some degree.
Santarus, Inc. (SNTS) Is a Real Gas!
Investing in the stock market can sometimes be a gut wrenching experience. However, for investors in Santarus, Inc.
AstraZeneca plc (ADR) (AZN), BAE Systems PLC (ADR) (BAESY): Three Neil Woodford High-Yield Shares
LONDON -- Ace City investor Neil Woodford has thrashed the FTSE 100 over the last five, 10, and 15 years.
AstraZeneca plc (ADR) (AZN): Do Major Drug Manufacturers Have Room to Grow?
Major drug manufacturers are literally a market sector unto themselves.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN) – Pick Your Poison: Overweight or High Cholesterol
Overweight and have high cholesterol? You may have to pick one to work on at a time, according to data from the lab of John Thyfault, an associate professor of nutrition and exercise...
Pfizer Inc. (PFE), AstraZeneca plc (ADR) (AZN): Statin Users May Have a Reason to Rejoice After This Data
Whether or not you've been keeping tabs, the American Society of Clinical Oncology's annual meeting is less than two weeks away.
MannKind Corporation (MNKD): Why Have Shares Moved?
MannKind Corporation (NASDAQ:MNKD) took one giant leap over the past few days.
AstraZeneca plc (ADR) (AZN): The Latest News
AstraZeneca plc (ADR) (NYSE:AZN)'s in a tight spot.
AstraZeneca plc (AZN): How Does It Stack Up?
LONDON -- Dividend income accounts for around two-thirds of total returns, the actual rate of return taking into account both capital and income appreciation.
AstraZeneca plc (ADR) (AZN): Where Investment Dollars Are Headed
As I noted 10 weeks ago, cancer statistics are both staggering and disappointing.
SolarCity Corp (SCTY), Exelixis, Inc. (EXEL): Watch These Stocks
I follow quite a lot of companies, so the usefulness of a watchlist to me cannot be overstated.
Edwards Lifesciences Corp (EW), Sarepta Therapeutics Inc (SRPT), Rigel Pharmaceuticals, Inc. (RIGL): April’s Unhealthiest Stocks
Leading health-care stocks have had a good start to the year, but all's not healthy in the world of medicine.
Merck & Co., Inc. (MRK), Pfizer Inc. (PFE): FDA Approves Powerful New Cholesterol Drug
Merck & Co., Inc. (NYSE:MRK) gained Food and Drug Administration approval for its powerful new cholesterol drug Liptruzet, a combination of two already-approved drugs, Pfizer...
Pfizer Inc. (PFE), Eli Lilly & Co. (LLY) & Other Names To Know: A Full Breakdown
Investing in biotech companies can be intimidating, especially for investors without a science background. But there's hope.
Merck & Co., Inc. (MRK): Post-Earnings Performance Questions
Merck & Co., Inc. (NYSE:MRK) stock could move up or down this week after the pharmaceutical company reports earnings on Wednesday.
Galena Biopharma Inc (GALE), Gilead Sciences, Inc. (GILD): Two Biopharmaceutical Companies Worth Buying
The biotechnology industry had a good time last year and the market expects the trend to continue in 2013 as well.
AstraZeneca plc (ADR) (AZN): Is It The Ultimate Stock Picker’s Share?
AstraZeneca plc (ADR) (NYSE:AZN) is the 12th biggest company in the FTSE 100. It is a true blue chip.
